Market Insight - Advanced therapies regulation: perspectives from the EU
This article was originally published in Scrip
The human body has become an important source for components of pharmaceuticals and medical devices used to treat diseases and malfunctions. Increasingly, these so-called "advanced therapies" are being developed from blood, cells, skin, bone and human tissues. Their use has revolutionised the treatment of several diseases and injuries, such as cancer, Parkinson's disease, burns and cartilage injuries.